10-Q · May 15, 2026
Forum Markets, Incorporated reported Q1 2026 results marked by a total revenue of $2.9 million, a significant increase from no revenue a year prior, driven by a strategic shift towards a digital asset-focused business…
Earnings analysis · 10-Q
FRMM earnings analysis
Filed August 14, 2026 · Our reading of the company's report
The latest report
Forum Markets reported Q2 revenue of $1.365 million, down from $3.0 million in Q1 2026 and well below the $3.22 million consensus estimate. Diluted EPS improved to negative $0.73 from negative $3.58, but still missed…
Read full summary
Forum Markets reported Q2 revenue of $1.365 million, down from $3.0 million in Q1 2026 and well below the $3.22 million consensus estimate. Diluted EPS improved to negative $0.73 from negative $3.58, but still missed the negative $0.27 estimate. The filing provides no quantitative guidance and highlights ineffective disclosure controls as of June 30, 2026, alongside new risks related to acquisitions, strategic alternatives, and discretionary repurchases.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $-0.73
What stood out
-
Revenue declined sharply and missed estimates
Q2 revenue was $1.365 million versus $3.0 million in Q1 2026, a sequential decline of approximately 54.5%; revenue also missed the $3.22 million consensus estimate by approximately 57.6%.
-
EPS improved sequentially but missed consensus
Diluted EPS was negative $0.73 versus negative $3.58 in Q1 2026, an improvement of $2.85 per share, but it missed the negative $0.27 consensus estimate by $0.46.
-
Control remediation remains underway
Management stated that disclosure controls were not effective as of June 30, 2026, and reiterated that internal control over financial reporting was not effective as of December 31, 2025.
-
ERP and control enhancements implemented
The company implemented a new NetSuite ERP system in the fourth quarter of 2025 and added automated systems intended to improve internal control over financial reporting.
-
Share repurchase activity continued
During Q2, the company repurchased 7,086,811 shares under its program; the amended program permits repurchases of up to $100.0 million and expires no later than June 30, 2027.
What to watch
-
Acquisition integration and funding risk
The company identified acquisitions as a substantive changed risk. It disclosed that future acquisitions could be difficult to integrate and could increase expenses, disrupt ongoing operations, and divert management attention; the Q1 2026 analysis also referenced an approximately $12 million aircraft-engine acquisition.
-
Strategic alternatives create execution risk
The company added a substantive changed risk concerning strategic alternatives, including a potential acquisition, merger, sale, strategic partnership, capital raise, or distribution of capital and assets. The process could involve significant transaction costs, dilution, disruption, or a decline in the common-stock price.
-
Repurchases may consume liquidity
The company added a substantive changed risk for discretionary stock repurchases. Since August 22, 2025, it purchased 9,515,782 shares for $79.5 million at an average price of $8.45, while the program can be suspended or terminated based on liquidity and other factors.
-
Material weakness in financial reporting controls
Disclosure controls were determined to be ineffective as of June 30, 2026, and the previously identified material weakness relates to classification and technical accounting review of significant one-time transactions.
-
Revenue volatility and estimate miss
Q2 revenue of $1.365 million was approximately 54.5% below Q1 revenue of $3.0 million and approximately 57.6% below the $3.22 million consensus estimate, indicating substantial near-term operating volatility.
Management's outlook
No quantitative revenue or EPS outlook was provided in the extracted 10-Q text; numeric fields left null.
Earlier filings 4
10-K · April 1, 2026
Forum Markets (FRMM) completed a strategic pivot in 2025–early 2026 from legacy pharma/iGaming to building an RWA tokenization platform supported by capital markets and blockchain infrastructure. Management raised…
10-Q · November 14, 2025
Ethzilla (formerly 180 Life Sciences) reported first substantial quarter after a strategic pivot to digital asset staking. Revenue of $4,110,169 was generated (new staking revenue), but operating loss widened to…
10-Q · July 23, 2025
180 Life Sciences (FRMM) remains a pre-revenue company; it reported a net loss of $1,726,604 for the quarter and $4,095,836 for the six months ended June 30, 2025 and had $2,218,331 in cash at quarter end. Management is…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.